
News|Articles|March 25, 2026
Navigating complex manufacturing for highly potent oral solid doses
Author(s)Pfizer CentreOne
Trending on Pharmaceutical Technology
1
What FDA's AI Warning Letter Tells Us About GMP Accountability
2
Daraxonrasib Review Signals Shift in EU Drug Assessment Rules
3
The Role of Standards in the Drug Supply Chain
4
Why Are Drugmakers Racing to Acquire ADC Payload Platforms?
5